-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Anticoagulation at the End of Life: Whether, When, and How to Treat

Program: Education Program
Session: Hematologic Challenges at the End-of-Life
Hematology Disease Topics & Pathways:
Research, Clinical Research, Health outcomes research
Saturday, December 7, 2024, 2:00 PM-3:15 PM

Anna L. Parks, MD

Department of Medicine, Division of Hematology & Hematologic Malignancies, University of Utah Health, Salt Lake City, UT

Disclosures: No relevant conflicts of interest to declare.

See more of: Hematologic Challenges at the End-of-Life
See more of: Education Program
<< Previous Presentation | Next Presentation >>